Aclaris Therapeutics
ACRS
#8548
Rank
A$0.22 B
Marketcap
$2.11
Share price
1.49%
Change (1 day)
13.27%
Change (1 year)

EPS for Aclaris Therapeutics (ACRS)

EPS in 2023 (TTM): -$2.32

According to Aclaris Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.41. In 2022 the company made an earnings per share (EPS) of -$2.07 an increase over its 2021 EPS that were of -$2.53.

EPS history for Aclaris Therapeutics from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.3212.43%
2022-$2.07-18.4%
2021-$2.5335.83%
2020-$1.86-69.31%
2019-$6.07-3.22%
2018-$6.2867.63%
2017-$3.746.64%
2016-$3.5166.73%
2015-$2.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.39 40.65%๐Ÿ‡บ๐Ÿ‡ธ USA